Entero Therapeutics Inc (ENTO)
2.74
+0.11
(+4.18%)
USD |
NASDAQ |
May 31, 16:00
2.75
+0.01
(+0.36%)
After-Hours: 20:00
Entero Therapeutics Cash and Short Term Investments (Quarterly): 3.432M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.432M |
December 31, 2023 | 3.712M |
September 30, 2023 | 3.292M |
June 30, 2023 | 1.236M |
March 31, 2023 | 2.064M |
December 31, 2022 | 1.363M |
September 30, 2022 | 1.657M |
June 30, 2022 | 1.155M |
March 31, 2022 | 5.695M |
December 31, 2021 | 8.249M |
September 30, 2021 | 7.211M |
June 30, 2021 | 8.074M |
March 31, 2021 | 12.03M |
December 31, 2020 | 6.062M |
September 30, 2020 | 11.37M |
June 30, 2020 | 0.9849M |
March 31, 2020 | 1.63M |
Date | Value |
---|---|
December 31, 2019 | 0.1758M |
September 30, 2019 | 1.550M |
June 30, 2019 | 1.311M |
March 31, 2019 | 0.4139M |
December 31, 2018 | 1.114M |
September 30, 2018 | 4.428M |
June 30, 2018 | 7.420M |
March 31, 2018 | 0.5745M |
December 31, 2017 | 0.5735M |
September 30, 2017 | 2.946M |
June 30, 2017 | 3.829M |
March 31, 2017 | 0.5319M |
December 31, 2016 | 1.774M |
September 30, 2016 | 0.1285M |
June 30, 2016 | 1.389M |
March 31, 2016 | 0.2134M |
December 31, 2015 | 0.6385M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.1758M
Minimum
Dec 2019
12.03M
Maximum
Mar 2021
4.112M
Average
2.678M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
BioVie Inc | 30.35M |
Jaguar Health Inc | 11.67M |
Benitec Biopharma Inc | 14.14M |
Immuneering Corp | 71.28M |
NovaBay Pharmaceuticals Inc | 1.823M |